Skip to main content
logo
BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.3544
-0.0520 (-12.80%)
At close: Jun 2, 2026, 4:00 PM EDT
0.3577
+0.0033 (0.93%)
Pre-market: Jun 3, 2026, 8:40 AM EDT

BioRestorative Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.06-14.24-8.98-10.42-13.22-44.3
Depreciation & Amortization
0.210.210.190.170.120.09
Stock-Based Compensation
1.613.332.817.7812.6123.11
Other Adjustments
-3.15-1.39-2.28-4.48-5.4417.45
Change in Receivables
0.010.17-0.17-0-0.010.01
Changes in Accounts Payable
0.040.840.290.020.12-0.07
Changes in Accrued Expenses
0.60.20.030.58-00.81
Changes in Unearned Revenue
-0.15-----
Changes in Other Operating Activities
0.070.1-0.13-0.08-0.09-0.43
Operating Cash Flow
-11.82-10.79-8.23-6.43-5.91-3.33
Capital Expenditures
-0.08-0.12-0.11-0.17-0.27-0.03
Purchases of Intangible Assets
-----0.18-
Purchases of Investments
-1.7-2.68-20.89-17.54-22.45-
Proceeds from Sale of Investments
9.2811.6921.5120.969.49-
Investing Cash Flow
7.58.90.513.25-13.4-0.03
Short-Term Debt Issued
-----0.25
Net Short-Term Debt Issued (Repaid)
-----0.25
Issuance of Common Stock
5.933.147.532.35-21.07
Net Common Stock Issued (Repurchased)
5.933.147.532.35-21.07
Other Financing Activities
-0.8-0.28-0.15---
Financing Cash Flow
6.22.857.382.35-21.32
Net Cash Flow
1.880.96-0.34-0.83-19.3117.96
Free Cash Flow
-11.9-10.91-8.34-6.6-6.18-3.36
FCF Margin
-3324.57%-3031.70%-2078.94%-4527.61%-5157.20%-7305.58%
Free Cash Flow Per Share
-1.05-1.21-1.07-1.56-1.71-2.83
Levered Free Cash Flow
-10.37-13.01-8.7-9.9-13.34-43.68
Unlevered Free Cash Flow
-13.86-14.75-11.65-14.85-19.21-25.98
SEC Filings: 10-K · 10-Q